Palisade Bio, Inc. (PALI)

Palisade Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0	0.25	0	0	0	0.02
Revenue Growth (YoY)	-	-	-	-	-	-94.08%
Gross Profit	0	0.25	0	0	0	0.02
Selling, General & Admin	6.12	6.2	8.76	9.31	6.2	4.59
Research & Development	7.87	6.89	6.55	2.43	3.1	4.06
Other Operating Expenses	0.23	0.23	0.41	30.12	0	0
Operating Expenses	14.21	13.32	15.72	41.85	9.3	8.65
Operating Income	-14.21	-13.07	-15.72	-41.85	-9.3	-8.63
Interest Expense / Income	0.02	0.02	0.01	2.4	0.24	0.01
Other Expense / Income	-0.73	-0.77	-1.19	-17.64	0.79	-0.29
Pretax Income	-13.5	-12.32	-14.55	-26.62	-10.32	-8.35
Net Income	-13.5	-12.32	-14.55	-26.62	-10.32	-8.35
Shares Outstanding (Basic)	1	0	0	0	0	0
Shares Outstanding (Diluted)	1	0	0	0	0	0
Shares Change	166.99%	677.03%	370.85%	236.96%	657.99%	236.55%
EPS (Basic)	-23.64	-27.00	-247.95	-2144.25	-2790.00	-17100.00
EPS (Diluted)	-23.64	-27.00	-247.95	-2546.10	-2790.00	-17100.00
Free Cash Flow	-10.79	-11.14	-13.37	-14.77	-4.77	-7.26
Free Cash Flow Per Share	-14.04	-24.42	-227.82	-1190.12	-1290.56	-14858.48
Gross Margin	-	100.00%	-	-	-	100.00%
Operating Margin	-	-5228.00%	-	-	-	-56071.81%
Profit Margin	-	-4926.40%	-	-	-	-54252.64%
Free Cash Flow Margin	-	-4454.80%	-	-	-	-47133.17%
EBITDA	-13.38	-12.2	-14.37	-24.05	-9.94	-8.2
EBITDA Margin	-	-4878.00%	-	-	-	-53260.18%
Depreciation & Amortization	0.11	0.11	0.17	0.17	0.15	0.14
EBIT	-13.49	-12.3	-14.54	-24.22	-10.09	-8.34
EBIT Margin	-	-4920.40%	-	-	-	-54194.69%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).